Adherence to evidence‐based practice in the treatment of digoxin poisoning in New South Wales, Australia
British Journal of Clinical Pharmacology · 2025
DOI: 10.1002/bcp.70326 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Betty S Chan und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Digoxin, Guideline Adherence, Evidence-Based Practice, Immunoglobulin Fab Fragments. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Aims
Traditionally, large doses of digoxin antibody (Digoxin‐Fab) were prescribed for digoxin poisoning. However, recent studies advocate for smaller, titrated doses for acute cases and a single vial for chronic digoxin poisoning. The Australian Therapeutic Guidelines updated their recommendations to align with this evidence in August 2020. This study aims to investigate whether Australian clinical toxicologists adhere to these new guidelines.
Methods
This retrospective review (2017–2022) analyses the advice given by toxicologists for digoxin poisoning to determine adherence to the Therapeutic Guidelines. Patient were identified through the New South Wales Poisons Information Centre database, that were referred to toxicologists. The advice provided by toxicologists was evaluated against the guidelines at the time of the consultation.
Results
The study examined 149 chronic digoxin poisoning cases from 34 hospitals and 17 acute digoxin poisoning cases from 14 hospitals. From January 2017 to July 2020 (pre‐new guidelines), advice was given for 86 chronic and 12 acute cases. Following guideline update (August 2020 to December 2022), advice was given for 63 chronic and 5 acute cases. Prior to August 2020, 35% of chronic cases adhered to the old guidelines, while 64% followed the new guidelines, improving to 95% post‐August 2020 (p < 0.0001). For acute cases, no advice followed the old guidelines before August 2020, but 83% and 100% adhered to the new guidelines before and after August 2020, respectively.
Conclusions
The study shows that Australian clinical toxicologists began integrating new research findings before the 2020 guideline update, with significant improvement in adherence for digoxin poisoning cases post‐August 2020.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia.
- Department of Clinical Toxicology, Department of Emergency Medicine, Prince of Wales Hospital, Randwick, New South Wales, Australia.
- New South Wales Poisons Information Centre, The Children's Hospital at Westmead, Westmead, New South Wales, Australia.
- Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
ORCID-Profile: Betty S Chan
Zitieren
APA
Chan, B. S., Jeong, J., Cairns, R., & Buckley, N. A. (2025). Adherence to evidence‐based practice in the treatment of digoxin poisoning in New South Wales, Australia. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70326
Vancouver
Chan BS, Jeong J, Cairns R, Buckley NA. Adherence to evidence‐based practice in the treatment of digoxin poisoning in New South Wales, Australia. British Journal of Clinical Pharmacology. 2025. doi:10.1002/bcp.70326
BibTeX
@article{Chan2025,
author = {Chan, Betty S and Jeong, Julia and Cairns, Rose and Buckley, Nicholas A},
title = {Adherence to evidence‐based practice in the treatment of digoxin poisoning in New South Wales, Australia},
journal = {British Journal of Clinical Pharmacology},
year = {2025},
doi = {10.1002/bcp.70326}
}
EUVIMED